LGALS9 and B-cell chronic lymphocytic leukemia: By applying this differential analysis using CellChat, we identified HLA–LAG3, BTLA–CD247, ENTPD1–ADORA2A, and LGALS9–TIM3 ligand–receptor pairs as relevant inhibitory signals in CLL LNs, which were absent in rLN [86].